# Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

> **NCT02543658** · PHASE2 · COMPLETED · sponsor: **The First Affiliated Hospital of Nanchang University** · enrollment: 80 (actual)

## Conditions studied

- Acute Pancreatitis
- Intra-abdominal Hypertension

## Interventions

- **DRUG:** Neostigmine Methylsulfate 1 MG/ML
- **COMBINATION_PRODUCT:** Conservative treatment

## Key facts

- **NCT ID:** NCT02543658
- **Lead sponsor:** The First Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2017-08-15
- **Final completion:** 2018-05-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02543658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02543658, "Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02543658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*